Lonza: Starts 2017 With Outstanding First Quarter.

25 Apr 2017 13:49

Strong start in Q1 paves way for double-digit organic sales growth for first half year. CORE EBIT growth expected to be even stronger than sales growth for first half of 2017. Pharma&Biotech with strong performance in revenue and profitability. Specialty Ingredients with robust growth and profitability improvement. Outlook 2017 upgraded...

Attachments: